EAM Global Investors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-49,796
Closed -$773K 123
2019
Q3
$773K Sell
49,796
-41,536
-45% -$645K 0.38% 109
2019
Q2
$1.85M Hold
91,332
0.79% 41
2019
Q1
$1.61M Sell
91,332
-11,793
-11% -$207K 0.71% 62
2018
Q4
$1.32M Hold
103,125
0.72% 70
2018
Q3
$1.68M Buy
103,125
+25,236
+32% +$411K 0.68% 48
2018
Q2
$883K Hold
77,889
0.43% 136
2018
Q1
$760K Buy
+77,889
New +$760K 0.39% 127